Alan M Jacobson1, Barbara H Braffett2, Guray Erus3, Christopher M Ryan4, Geert J Biessels5, José A Luchsinger6, Ionut Bebu2, Rose A Gubitosi-Klug7, Lisa Desiderio3, Gayle M Lorenzi8, Victoria R Trapani3, John M Lachin3, R Nick Bryan9, Mohamad Habes10, Ilya M Nasrallah3. 1. NYU Long Island School of Medicine, NYU Langone Hospital-Long Island, Mineola. 2. The Biostatistics Center, The George Washington University, Rockville, MD. 3. Department of Radiology, University of Pennsylvania, Philadelphia, PA. 4. University of Pittsburgh, Pittsburgh, PA. 5. Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Netherlands. 6. Columbia University Irving Medical Center, New York, NY. 7. Case Western Reserve University School of Medicine, Rainbow Babies & Children's Hospital, Cleveland, OH. 8. University of California San Diego, La Jolla, CA. 9. The University of Texas at Austin, Austin, TX. 10. Neuroimage Analytics Laboratory and Biggs Institute Neuroimaging Core, Glenn Biggs Institute for Neurodegenerative Disorders, University of Texas Health Science Center at San Antonio, San Antonio, TX.
Abstract
OBJECTIVE: Individuals with type 1 diabetes mellitus (T1DM) are living to ages when neuropathological changes are increasingly evident. We hypothesized that middle-aged and older adults with long-standing T1DM will show abnormal brain structure in comparison with control subjects without diabetes. RESEARCH DESIGN AND METHODS: MRI was used to compare brain structure among 416 T1DM participants in the Epidemiology of Diabetes Interventions and Complications (EDIC) study with that of 99 demographically similar control subjects without diabetes at 26 U.S. and Canadian sites. Assessments included total brain (TBV) (primary outcome), gray matter (GMV), white matter (WMV), ventricle, and white matter hyperintensity (WMH) volumes and total white matter mean fractional anisotropy (FA). Biomedical assessments included HbA1c and lipid levels, blood pressure, and cognitive assessments of memory and psychomotor and mental efficiency (PME). Among EDIC participants, HbA1c, severe hypoglycemia history, and vascular complications were measured longitudinally. RESULTS: Mean age of EDIC participants and control subjects was 60 years. T1DM participants showed significantly smaller TBV (least squares mean ± SE 1,206 ± 1.7 vs. 1,229 ± 3.5 cm3, P < 0.0001), GMV, and WMV and greater ventricle and WMH volumes but no differences in total white matter mean FA versus control subjects. Structural MRI measures in T1DM were equivalent to those of control subjects who were 4-9 years older. Lower PME scores were associated with altered brain structure on all MRI measures in T1DM participants. CONCLUSIONS: Middle-aged and older adults with T1DM showed brain volume loss and increased vascular injury in comparison with control subjects without diabetes, equivalent to 4-9 years of brain aging.
OBJECTIVE: Individuals with type 1 diabetes mellitus (T1DM) are living to ages when neuropathological changes are increasingly evident. We hypothesized that middle-aged and older adults with long-standing T1DM will show abnormal brain structure in comparison with control subjects without diabetes. RESEARCH DESIGN AND METHODS: MRI was used to compare brain structure among 416 T1DM participants in the Epidemiology of Diabetes Interventions and Complications (EDIC) study with that of 99 demographically similar control subjects without diabetes at 26 U.S. and Canadian sites. Assessments included total brain (TBV) (primary outcome), gray matter (GMV), white matter (WMV), ventricle, and white matter hyperintensity (WMH) volumes and total white matter mean fractional anisotropy (FA). Biomedical assessments included HbA1c and lipid levels, blood pressure, and cognitive assessments of memory and psychomotor and mental efficiency (PME). Among EDIC participants, HbA1c, severe hypoglycemia history, and vascular complications were measured longitudinally. RESULTS: Mean age of EDIC participants and control subjects was 60 years. T1DM participants showed significantly smaller TBV (least squares mean ± SE 1,206 ± 1.7 vs. 1,229 ± 3.5 cm3, P < 0.0001), GMV, and WMV and greater ventricle and WMH volumes but no differences in total white matter mean FA versus control subjects. Structural MRI measures in T1DM were equivalent to those of control subjects who were 4-9 years older. Lower PME scores were associated with altered brain structure on all MRI measures in T1DM participants. CONCLUSIONS: Middle-aged and older adults with T1DM showed brain volume loss and increased vascular injury in comparison with control subjects without diabetes, equivalent to 4-9 years of brain aging.
Authors: Karen A Nunley; Christopher M Ryan; Trevor J Orchard; Howard J Aizenstein; J Richard Jennings; John Ryan; Janice C Zgibor; Robert M Boudreau; Tina Costacou; John D Maynard; Rachel G Miller; Caterina Rosano Journal: Neurology Date: 2015-04-22 Impact factor: 9.910
Authors: Nicholas J Tustison; Brian B Avants; Philip A Cook; Yuanjie Zheng; Alexander Egan; Paul A Yushkevich; James C Gee Journal: IEEE Trans Med Imaging Date: 2010-04-08 Impact factor: 10.048
Authors: Jimit Doshi; Guray Erus; Yangming Ou; Susan M Resnick; Ruben C Gur; Raquel E Gur; Theodore D Satterthwaite; Susan Furth; Christos Davatzikos Journal: Neuroimage Date: 2015-12-08 Impact factor: 6.556
Authors: Ilya M Nasrallah; Nicholas M Pajewski; Alexander P Auchus; Gordon Chelune; Alfred K Cheung; Maryjo L Cleveland; Laura H Coker; Michael G Crowe; William C Cushman; Jeffrey A Cutler; Christos Davatzikos; Lisa Desiderio; Jimit Doshi; Guray Erus; Larry J Fine; Sarah A Gaussoin; Darrin Harris; Karen C Johnson; Paul L Kimmel; Manjula Kurella Tamura; Lenore J Launer; Alan J Lerner; Cora E Lewis; Jennifer Martindale-Adams; Claudia S Moy; Linda O Nichols; Suzanne Oparil; Paula K Ogrocki; Mahboob Rahman; Stephen R Rapp; David M Reboussin; Michael V Rocco; Bonnie C Sachs; Kaycee M Sink; Carolyn H Still; Mark A Supiano; Joni K Snyder; Virginia G Wadley; Jennifer Walker; Daniel E Weiner; Paul K Whelton; Valerie M Wilson; Nancy Woolard; Jackson T Wright; Clinton B Wright; Jeff D Williamson; R Nick Bryan Journal: JAMA Date: 2019-08-13 Impact factor: 56.272
Authors: Dana C Perantie; Jonathan M Koller; Patrick M Weaver; Heather M Lugar; Kevin J Black; Neil H White; Tamara Hershey Journal: Diabetes Date: 2011-09-27 Impact factor: 9.461
Authors: Simon R Cox; Donald M Lyall; Stuart J Ritchie; Mark E Bastin; Mathew A Harris; Colin R Buchanan; Chloe Fawns-Ritchie; Miruna C Barbu; Laura de Nooij; Lianne M Reus; Clara Alloza; Xueyi Shen; Emma Neilson; Helen L Alderson; Stuart Hunter; David C Liewald; Heather C Whalley; Andrew M McIntosh; Stephen M Lawrie; Jill P Pell; Elliot M Tucker-Drob; Joanna M Wardlaw; Catharine R Gale; Ian J Deary Journal: Eur Heart J Date: 2019-07-21 Impact factor: 29.983
Authors: Abdulmajeed Alotaibi; Christopher Tench; Rebecca Stevenson; Ghadah Felmban; Amjad Altokhis; Ali Aldhebaib; Rob A Dineen; Cris S Constantinescu Journal: Brain Sci Date: 2021-01-22